Presence of 1q21 Gain and Amplification May be Associated With Poorer Outcomes in Daratumumab-treated Multiple Myeloma Patients

Kenneth J.C. Lim; Cameron Wellard; Elizabeth Moore; Slavisa Ninkovic; Wee Joo Chng; Andrew Spencer; Peter Mollee; Jay Hocking; Phoebe Joy Ho; Wojt Janowski; Kihyun Kim; Georgia McCaughan; Karen Dun; Zoe K. McQuilten; Fiona Chen; Hang Quach

doi:10.1016/j.clml.2024.11.002

Presence of 1q21 Gain and Amplification May be Associated With Poorer Outcomes in Daratumumab-treated Multiple Myeloma Patients

Kenneth J.C. Lim, Cameron Wellard, Elizabeth Moore, Slavisa Ninkovic, Wee Joo Chng, Andrew Spencer, Peter Mollee, Jay Hocking, Phoebe Joy Ho, Wojt Janowski, Kihyun Kim, Georgia McCaughan, Karen Dun, Zoe K. McQuilten, Fiona Chen, Hang Quach

Research output: Contribution to journal › Article › Research › peer-review

Original language	English
Number of pages	6
Journal	Clinical Lymphoma, Myeloma and Leukemia
DOIs	https://doi.org/10.1016/j.clml.2024.11.002
Publication status	Accepted/In press - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.clml.2024.11.002

Cite this

Lim, K. J. C., Wellard, C., Moore, E., Ninkovic, S., Chng, W. J., Spencer, A., Mollee, P., Hocking, J., Ho, P. J., Janowski, W., Kim, K., McCaughan, G., Dun, K., McQuilten, Z. K., Chen, F., & Quach, H. (Accepted/In press). Presence of 1q21 Gain and Amplification May be Associated With Poorer Outcomes in Daratumumab-treated Multiple Myeloma Patients. Clinical Lymphoma, Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2024.11.002

@article{4677858516a84075a2b63b48874beecb,

title = "Presence of 1q21 Gain and Amplification May be Associated With Poorer Outcomes in Daratumumab-treated Multiple Myeloma Patients",

author = "Lim, {Kenneth J.C.} and Cameron Wellard and Elizabeth Moore and Slavisa Ninkovic and Chng, {Wee Joo} and Andrew Spencer and Peter Mollee and Jay Hocking and Ho, {Phoebe Joy} and Wojt Janowski and Kihyun Kim and Georgia McCaughan and Karen Dun and McQuilten, {Zoe K.} and Fiona Chen and Hang Quach",

year = "2024",

doi = "10.1016/j.clml.2024.11.002",

language = "English",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Elsevier",

}

Lim, KJC, Wellard, C, Moore, E, Ninkovic, S, Chng, WJ, Spencer, A, Mollee, P, Hocking, J, Ho, PJ, Janowski, W, Kim, K, McCaughan, G, Dun, K, McQuilten, ZK, Chen, F & Quach, H 2024, 'Presence of 1q21 Gain and Amplification May be Associated With Poorer Outcomes in Daratumumab-treated Multiple Myeloma Patients', Clinical Lymphoma, Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2024.11.002

TY - JOUR

T1 - Presence of 1q21 Gain and Amplification May be Associated With Poorer Outcomes in Daratumumab-treated Multiple Myeloma Patients

AU - Lim, Kenneth J.C.

AU - Wellard, Cameron

AU - Moore, Elizabeth

AU - Ninkovic, Slavisa

AU - Chng, Wee Joo

AU - Spencer, Andrew

AU - Mollee, Peter

AU - Hocking, Jay

AU - Ho, Phoebe Joy

AU - Janowski, Wojt

AU - Kim, Kihyun

AU - McCaughan, Georgia

AU - Dun, Karen

AU - McQuilten, Zoe K.

AU - Chen, Fiona

AU - Quach, Hang

PY - 2024

Y1 - 2024

UR - http://www.scopus.com/inward/record.url?scp=85210740440&partnerID=8YFLogxK

U2 - 10.1016/j.clml.2024.11.002

DO - 10.1016/j.clml.2024.11.002

M3 - Article

C2 - 39616008

AN - SCOPUS:85210740440

SN - 2152-2650

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

ER -

Presence of 1q21 Gain and Amplification May be Associated With Poorer Outcomes in Daratumumab-treated Multiple Myeloma Patients

UN SDGs

Access to Document

Other files and links

Cite this